Gerald W. A. Slywka
Gerald W. A. Slywka publishes mostly in Pediatrics, Perinatology and Child Health, Economics and Econometrics and Immunology, on topics such as Pharmaceutical studies and practices, Biosimilars and Bioanalytical Methods and Pharmaceutical Economics and Policy.
- World rank
- #5,528,319 of 7,710,434 ranked researchers
- Rank in United States
- #1,390,596 of 1,627,098
- Works
- 15
- Citations
- 190
- Citations per work
- 12.7
What does Gerald W. A. Slywka research?
Gerald W. A. Slywka's work is mostly in Medicine (22%), Economics, Econometrics and Finance (12%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else748.8%
- Health Sciences321.9%
- Medicine321.9%
- Life Sciences317.1%
- Social Sciences212.2%
- 1Pediatrics, Perinatology and Child Health15% of their works
- 2Economics and Econometrics12% of their works
- 3Immunology7% of their works
- 4Pharmacology7% of their works
- 5Pharmacology5% of their works
- 6Plant Science5% of their works
Research topics
- Pharmaceutical studies and practices
- Biosimilars and Bioanalytical Methods
- Pharmaceutical Economics and Policy
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Health Systems, Economic Evaluations, Quality of Life
- Pharmacological Effects and Assays
- Botanical Research and Chemistry
Which keywords describe Gerald W. A. Slywka's research?
The keywords of their largest research topics: Off-Label Drug Use, Pediatric Pharmacokinetics, Biosimilars, Drug Development Costs, Generic Drugs, Immunogenicity, Antibiotic Pharmacokinetics and Cost-effectiveness Analysis.
- Secondary Metabolites
- Lupin Seeds
- Quality of Life
- Cytochrome P450
- Cost-effectiveness Analysis
- Immunogenicity
- Drug Development Costs
- Pediatric Pharmacokinetics
- Off-Label Drug Use
- Biosimilars
- Generic Drugs
- Antibiotic Pharmacokinetics
- Critically Ill Patients
- Pharmacogenetics
- Clenbuterol
- Ractopamine
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Off-Label Drug Use41 topic
- Pediatric Pharmacokinetics41 topic
- Biosimilars31 topic
- Drug Development Costs31 topic
- Generic Drugs31 topic
- Immunogenicity31 topic
- Antibiotic Pharmacokinetics21 topic
- Cost-effectiveness Analysis21 topic
- Critically Ill Patients21 topic
- Cytochrome P45021 topic
- Pharmacogenetics21 topic
- Quality of Life21 topic
- Clenbuterol11 topic
- Lupin Seeds11 topic
- Ractopamine11 topic
- Secondary Metabolites11 topic
Where does Gerald W. A. Slywka work?
Gerald W. A. Slywka's main affiliation in the publication record is University of Tennessee Health Science Center, United States.
How many publications and citations does Gerald W. A. Slywka have?
OpenAlex counts 15 works and 190 citations for Gerald W. A. Slywka, an h-index of 7, ranking #5,528,319 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gerald W. A. Slywka. Posts are plain text and can be reported.